| Feet For Life | |
|
811 10th Ave N, Bessemer, AL 35020-5320 | |
| (205) 424-9199 | |
| (205) 424-9189 |
| Full Name | Feet For Life |
|---|---|
| Type | Facility |
| Speciality | Podiatrist |
| Location | 811 10th Ave N, Bessemer, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649225475 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | (* (Not Available)) | Primary |
| Provider Name | Stephen L Stern |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1629016498 PECOS PAC ID: 3274556543 Enrollment ID: I20060112000636 |
News Archive
Par Pharmaceutical Companies, Inc. announced today that it has completed the acquisition of privately-held Edict Pharmaceuticals Private Limited, an India-based developer and manufacturer of generic pharmaceuticals.
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies and miRagen Therapeutics, Inc., a biopharmaceutical company focused on developing innovative microRNA-based therapeutics for cardiovascular and muscle disease, announced today that they have formed a strategic alliance to develop microRNA-targeted medicines for the treatment of cardiovascular disease.
In the 18 years that Kathy Brandt and Kim Acquaviva have been together, death has been a constant companion.
Teva Pharmaceutical Industries Ltd. announced today that MediWound Ltd., a company in which Teva holds an 11% interest, reported positive results from a pre planned interim analysis of a phase III trial for Debrase®, an enzymatic debriding agent for burns.
"Africa needs to boost agricultural productivity and address the debilitating hunger that affects 27 percent of its population if it is to sustain its economic boom, the United Nations Development Programme (UNDP) said in a report on Tuesday," Reuters reports.
› Verified 3 days ago
| Provider Name | Stewart Matthew Pierson |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1255749107 PECOS PAC ID: 3072868801 Enrollment ID: I20181130002123 |
News Archive
Par Pharmaceutical Companies, Inc. announced today that it has completed the acquisition of privately-held Edict Pharmaceuticals Private Limited, an India-based developer and manufacturer of generic pharmaceuticals.
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies and miRagen Therapeutics, Inc., a biopharmaceutical company focused on developing innovative microRNA-based therapeutics for cardiovascular and muscle disease, announced today that they have formed a strategic alliance to develop microRNA-targeted medicines for the treatment of cardiovascular disease.
In the 18 years that Kathy Brandt and Kim Acquaviva have been together, death has been a constant companion.
Teva Pharmaceutical Industries Ltd. announced today that MediWound Ltd., a company in which Teva holds an 11% interest, reported positive results from a pre planned interim analysis of a phase III trial for Debrase®, an enzymatic debriding agent for burns.
"Africa needs to boost agricultural productivity and address the debilitating hunger that affects 27 percent of its population if it is to sustain its economic boom, the United Nations Development Programme (UNDP) said in a report on Tuesday," Reuters reports.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Feet For Life 811 10th Ave N, Bessemer, AL 35020-5320 Ph: (205) 424-9199 | Feet For Life 811 10th Ave N, Bessemer, AL 35020-5320 Ph: (205) 424-9199 |
News Archive
Par Pharmaceutical Companies, Inc. announced today that it has completed the acquisition of privately-held Edict Pharmaceuticals Private Limited, an India-based developer and manufacturer of generic pharmaceuticals.
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies and miRagen Therapeutics, Inc., a biopharmaceutical company focused on developing innovative microRNA-based therapeutics for cardiovascular and muscle disease, announced today that they have formed a strategic alliance to develop microRNA-targeted medicines for the treatment of cardiovascular disease.
In the 18 years that Kathy Brandt and Kim Acquaviva have been together, death has been a constant companion.
Teva Pharmaceutical Industries Ltd. announced today that MediWound Ltd., a company in which Teva holds an 11% interest, reported positive results from a pre planned interim analysis of a phase III trial for Debrase®, an enzymatic debriding agent for burns.
"Africa needs to boost agricultural productivity and address the debilitating hunger that affects 27 percent of its population if it is to sustain its economic boom, the United Nations Development Programme (UNDP) said in a report on Tuesday," Reuters reports.
› Verified 3 days ago
Bessemer Family Foot Clinic Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 1721 4th Ave N, Bessemer, AL 35020 Phone: 205-424-2540 | |
Metro Podiatry & Sports Medicine Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 985 9th Ave Sw, Suite # 405, Bessemer, AL 35022 Phone: 205-481-8524 Fax: 205-481-8820 | |
Stewart Pierson, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 811 10th Ave N, Bessemer, AL 35020 Phone: 205-454-7251 Fax: 205-737-7647 | |
Footcare & Wellness Llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 985 9th Ave Sw, Suite 405, Bessemer, AL 35022 Phone: 205-481-8524 Fax: 205-481-8820 | |
Dr. Cynthia B Hobdy, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1721 4th Ave N, Bessemer, AL 35020 Phone: 205-424-2540 Fax: 205-424-3774 | |
Dr. Stephen L Stern, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 811 10th Ave N, Bessemer, AL 35020 Phone: 205-424-9199 Fax: 205-424-9189 |